1. Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients. (9th July 2014) Authors: Busch, A; Zeh, D; Janzen, V; Mügge, L-O; Wolf, D; Fingerhut, L; Hahn-Ast, C; Maurer, O; Brossart, P; von Lilienfeld-Toal, M Journal: Clinical and experimental immunology Issue: Volume 177:Number 2(2014:Aug.) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗